Auour Investments »

Atea Pharmaceuticals shares owned by Auour Investments

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Auour Investments from 13F filings

Historical chart of Auour Investments investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Auour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Auour Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $671k 177k 3.79
2023-09-30 $535k 177k 3.02
2023-06-30 $662k 177k 3.74

More positions owned by Auour Investments

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
Spdr Ser Tr Portfli Intrmdit (SPTI)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Spdr Ser Tr Portfolio Short (SPSB)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)

View all positions for Auour Investments

Top funds holding Atea Pharmaceuticals

EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Federated Investors
Charles Schwab Investment Management
Jacobs Levy Equity Management
Newtyn Management
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management
Bank of America Corporation
Bank of New York Mellon
Goldman Sachs Group
Barclays

View all funds holding Atea Pharmaceuticals